Advances in research on HBV inhibitors based on new targets (1): capsid protein inhibitors / 药学学报
Acta Pharmaceutica Sinica
;
(12): 554-565, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-820854
ABSTRACT
Hepatitis B virus (HBV) capsid protein plays an important role in the life cycle, thus becoming an ideal target for drug design. Capsid protein inhibitors can exert a synergistic antiviral effect with nucleoside drugs by inhibiting the replication of HBV. This paper reviews the research progress of capsid protein inhibitors with different structural types from the perspective of medicinal chemistry.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Acta Pharmaceutica Sinica
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS